# Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)

> **NCT04223999** · PHASE2 · UNKNOWN · sponsor: **Anders Rosendal Korshøj** · enrollment: 70 (estimated)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **PROCEDURE:** Skullremodeling surgery
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT04223999
- **Lead sponsor:** Anders Rosendal Korshøj
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-06-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04223999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04223999, "Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04223999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*